|
|
|
|
Unique upstream solutions for high-yield protein production
|
|
UniTargetingResearch AS
provides a unique technology for increasing protein production in mammalian cell systems for companies manufacturing recombinant proteins.
- Enhanced synthesis and secretion of naturally secreted proteins
e.g. antibodies,hormones,cytokines
- Enables direct secretion of intracellular proteins
e.g. cellular antigens.
UTR Clone Generation
Using UTR technologies together with a unique host and vector, we deliver tailor-made, high-producer clones with the ability to grow and produce in a lean protein free medium with high cell density.
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Press Release, 6 May 2007
Accuro Biologics Ltd, a privately held biotechnology services company, and UniTargetingResearch AS, a venture backed technology company, announce the execution of a two year service agreement. Under the agreement, Accuro Biologics will provide mammalian cell line development and other services to the UTR Clone Consortium using novel UTR technologies for increasing protein production. The terms of the deal were not disclosed.
|
|
Read more
|
|
|
|
|
|
Press Release, 27 October 2006
UniTargetingResearch AS (Bergen, Norway) has today announced the signing of a collaborative agreement with UCB (Euronext Brussels: UCB ) aimed at enhancing the yield of antibodies recombinantly produced by UCB in mammalian cell expression systems, in combination with UTR’s proprietary UTR®tech technology. The Agreement entails an initial transfer from UTR to UCB of an Evaluation License concurrent with the transfer of an option from UTR to UCB to license UTR®tech for commercial protein (antibody) manufacturing. The terms of the deal were not disclosed.
|
|
Read more
|
|
|
Archive
|
|
|
|
|
|
|
|
|
|
|
|
16 - 20 September; Angra dos Reis, Brazil
|
|
Read more
|
|
|
|
|
|
|
|
11 - 14 June 2007; Geneva, Switzerland
|
|
Read more
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|